Cargando…
Heterogeneity in potential impact and cost-effectiveness of ETEC and Shigella vaccination in four sub-Saharan African countries
Diarrheal disease burden has become more heterogenous in low- and lower middle-income countries as access to clean water, sanitation and health care has increased in wealthier urban populations. Enterotoxigenic Escherichia coli (ETEC) and Shigella are among the top five causes of diarrheal mortality...
Autores principales: | Anderson, John D., Muhib, Farzana, Rheingans, Richard, Wierzba, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819873/ https://www.ncbi.nlm.nih.gov/pubmed/31687662 http://dx.doi.org/10.1016/j.jvacx.2019.100043 |
Ejemplares similares
-
Potential impact and cost-effectiveness of future ETEC and Shigella vaccines in 79 low- and lower middle-income countries
por: Anderson, John D., et al.
Publicado: (2019) -
Heterogeneity in enterotoxigenic Escherichia coli and shigella infections in children under 5 years of age from 11 African countries: a subnational approach quantifying risk, mortality, morbidity, and stunting
por: Bagamian, Karoun H, et al.
Publicado: (2019) -
Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis
por: Anderson, John D, et al.
Publicado: (2019) -
Characterization of ShigETEC, a Novel Live Attenuated Combined Vaccine against Shigellae and ETEC
por: Harutyunyan, Shushan, et al.
Publicado: (2020) -
Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021
por: Bagamian, Karoun H., et al.
Publicado: (2022)